Therapeutic Potential of Targeting Prokineticin Receptors in Diseases

The prokineticins (PKs) were discovered approximately 20 years ago as small peptides inducing gut contractility. Today, they are established as angiogenic, anorectic, and proinflammatory cytokines, chemokines, hormones, and neuropeptides involved in variety of physiologic and pathophysiological path...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincenzi, Martina, Kremić, Amin, Jouve, Appoline, Lattanzi, Roberta, Miele, Rossella, Benharouga, Mohamed, Alfaidy, Nadia, Migrenne-Li, Stephanie, Kanthasamy, Anumantha G., Porcionatto, Marimelia, Ferrara, Napoleone, Tetko, Igor V., Désaubry, Laurent, Nebigil, Canan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595023/
https://www.ncbi.nlm.nih.gov/pubmed/37684054
http://dx.doi.org/10.1124/pharmrev.122.000801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595023/
https://www.ncbi.nlm.nih.gov/pubmed/37684054
http://dx.doi.org/10.1124/pharmrev.122.000801

Ejemplares similares